One Million Acute Insourced Dialysis Treatments Using Newer Technology

Background: Acute dialysis delivery is associated with significantly high cost of care. Reports on insourcing dialysis with newer technology have shown reduced cost, improved efficiency and similar, if not improved, outcomes. The Tablo® Hemodialysis System (Tablo) enables insourcing dialysis through its ease of use, integrated water purification, treatment flexibility (≤ 24 hours) and wireless data transmission. Methods: Transmitted data from Tablo’s cloud-based platform was filtered for acute treatments. Analysis included prescribed and achieved time and ultrafiltration (UF), alarms, and alarm resolution time. Treatments were grouped based on prescribed time: intermittent hemodialysis (IHD) and prolonged intermittent kidney replacement (PIKRT). Results were categorized as achieving the prescribed time within 5 minutes or termination prior. The latter were subdivided by device- or user-initiated (with or without an associated alarm), consistent with FDA guidance on real-world benefit-risk considerations and ISO 14971 standards. Clinically significant alarms were defined as alarms leading to blood pump stoppage. Alarm resolution was based on Tablo sensor data. Results: One million consecutive treatments from February 2022 to April 2025 at 628 facilities revealed 81.2% were completed within 5mins of prescribed and 13.2% were terminated >5mins with no associated alarm (Figure 1). Average cartridge use per treatment was 1.1 across all treatment times. Treatment breakdown, achieved time and UF, and alarm data are presented (Table 1). Conclusion: Insourced dialysis with newer technology has been reported to reduce cost and improve efficiency. This large data set from over 600 hospitals expands existing reports to include the clinical effectiveness of this model in achieving dialysis treatment goals for hospitalized patients. Funding: Commercial Support - Outset MedicalTable 1 - Treatment Category Treatments (n) Average Achieved Treatment Time (hrs) Average Prescribed Treatment TIme (hrs) Percent Time Achieved vs Prescribed Average Achieved Ultrafiltration (Liters) Average Prescrbed Ultrafiltration (Liters) Percent Ultrafiltration Achieved vs Prescribed Average Clinically Significant Alarms/treatment Average Alarm Resolution Time (secs) Alarm Rate per Hour Intermittent Hemodialysis 969,279 3.3 (+/-0.6) 3.3 (+/-0.6) 99.1% 1.9 (+/- 1.1) 1.9 (+/-1.1) 98.7% 2.1(+/-5.6) 5.6 (+/-16) 0.67 PIKRT 30,721 16.7 (+/-6.9) 16.6 (+/-7.0) 100.7% 3.1 (+/-2.2) 3.1 (+/-2.1) 99.3% 7.5 (+/-17) 15.3 (+/-57) 0.47 Total 1,000,000 3.6 (+/-2.3) 3.6 (+/-2.3) 98.7% 1.9 (+/-1.1) 1.9 (+/-1.1) 98.7% 2.3 (+/-6.3) 5.9 (+/-19) 0.64

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.202554t64f24
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

One Million Acute Insourced Dialysis Treatments Using Newer Technology

Elise Edson, Michael A. Aragon
Journal of the American Society of Nephrology
Dialysis and Renal Disease Management
article

One Million Acute Insourced Dialysis Treatments Using Newer Technology

Elise Edson, Michael A. Aragon
article en

Abstract

Background: Acute dialysis delivery is associated with significantly high cost of care. Reports on insourcing dialysis with newer technology have shown reduced cost, improved efficiency and similar, if not improved, outcomes. The Tablo® Hemodialysis System (Tablo) enables insourcing dialysis through its ease of use, integrated water purification, treatment flexibility (≤ 24 hours) and wireless data transmission. Methods: Transmitted data from Tablo’s cloud-based platform was filtered for acute treatments. Analysis included prescribed and achieved time and ultrafiltration (UF), alarms, and alarm resolution time. Treatments were grouped based on prescribed time: intermittent hemodialysis (IHD) and prolonged intermittent kidney replacement (PIKRT). Results were categorized as achieving the prescribed time within 5 minutes or termination prior. The latter were subdivided by device- or user-initiated (with or without an associated alarm), consistent with FDA guidance on real-world benefit-risk considerations and ISO 14971 standards. Clinically significant alarms were defined as alarms leading to blood pump stoppage. Alarm resolution was based on Tablo sensor data. Results: One million consecutive treatments from February 2022 to April 2025 at 628 facilities revealed 81.2% were completed within 5mins of prescribed and 13.2% were terminated >5mins with no associated alarm (Figure 1). Average cartridge use per treatment was 1.1 across all treatment times. Treatment breakdown, achieved time and UF, and alarm data are presented (Table 1). Conclusion: Insourced dialysis with newer technology has been reported to reduce cost and improve efficiency. This large data set from over 600 hospitals expands existing reports to include the clinical effectiveness of this model in achieving dialysis treatment goals for hospitalized patients. Funding: Commercial Support - Outset MedicalTable 1 - Treatment Category Treatments (n) Average Achieved Treatment Time (hrs) Average Prescribed Treatment TIme (hrs) Percent Time Achieved vs Prescribed Average Achieved Ultrafiltration (Liters) Average Prescrbed Ultrafiltration (Liters) Percent Ultrafiltration Achieved vs Prescribed Average Clinically Significant Alarms/treatment Average Alarm Resolution Time (secs) Alarm Rate per Hour Intermittent Hemodialysis 969,279 3.3 (+/-0.6) 3.3 (+/-0.6) 99.1% 1.9 (+/- 1.1) 1.9 (+/-1.1) 98.7% 2.1(+/-5.6) 5.6 (+/-16) 0.67 PIKRT 30,721 16.7 (+/-6.9) 16.6 (+/-7.0) 100.7% 3.1 (+/-2.2) 3.1 (+/-2.1) 99.3% 7.5 (+/-17) 15.3 (+/-57) 0.47 Total 1,000,000 3.6 (+/-2.3) 3.6 (+/-2.3) 98.7% 1.9 (+/-1.1) 1.9 (+/-1.1) 98.7% 2.3 (+/-6.3) 5.9 (+/-19) 0.64

Journal of the American Society of NephrologyVol. 36(10S)
California Institute for Medical Research (US)
Openalex Percentile: Top 65%
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.